M. Nienhuis

发表

Prognostic value of troponin after elective percutaneous coronary intervention: A meta‐analysis

J. Ottervanger, H. Bilo, F. Zijlstra, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Muscles alive: Ultrasound detects fibrillations

Nens van Alfen, Johannes P. van Dijk, S. Pillen, 2009, Clinical Neurophysiology.

Detection of fibrillations using muscle ultrasound: Diagnostic accuracy and identification of pitfalls

S. Pillen, M. Zwarts, N. Alfen, 2011, Muscle & nerve.

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Chapter 4 Troponin T elevation and prognosis after multivessel compared to single vessel elective percutaneous coronary intervention

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2008 .

Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Prognostic importance of troponin T and creatine kinase after elective angioplasty.

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, International journal of cardiology.

Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2008, American heart journal.

Comparison of frequency of periprocedural myocardial infarction in patients with and without diabetes mellitus to those with previously unknown but elevated glycated hemoglobin levels (from the TWENTE Trial).

J. W. Louwerenburg, M. Stoel, R. Stolk, 2012, The American journal of cardiology.

Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2009, Coronary artery disease.

Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Pre-treatment with clopidogrel and postprocedure troponin elevation after elective percutaneous coronary intervention

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, Thrombosis and Haemostasis.

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2014, The Lancet.

Prognostic importance of elevated troponin T and creatine kinase after elective angioplasty.

J. Ottervanger, M. Nienhuis, 2008, International journal of cardiology.

Prognostic implications of myocardial injury around percutaneous coronary interventions

M. Nienhuis, Marcus Bernardus Nienhuis, Marcus Bernardus Nienhuis, 2008 .

Prognostic implications of myocardial injury around percutaneous coronary interventions

J. Ottervanger, H. Suryapranata, M. de Boer, 2008 .

Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2013, Journal of the American College of Cardiology.

DUrable polymer-based sTent CHallenge of Promus ElemEnt versus ReSolute integrity (DUTCH PEERS): rationale and study design of a randomized multicenter trial in a Dutch all-comers population.

M. Stoel, C. von Birgelen, G. Linssen, 2012, American heart journal.

Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents.

M. Stoel, C. von Birgelen, G. Linssen, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Incidence of periprocedural myocardial infarction following stent implantation: Comparison between first‐ and second‐generation drug‐eluting stents

M. Stoel, C. von Birgelen, G. Linssen, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

CORONARY INTERVENT IONS

J. W. Louwerenburg, M. Stoel, G. Linssen, 2014 .

University of Groningen Prognostic implications of myocardial injury around percutaneous coronary interventions

J. Ottervanger, H. Bilo, B. Dikkeschei, 2008 .

Prognostic implications of myocardial injury around percutaneous coronary interventions

J. Ottervanger, H. Suryapranata, H. Bilo, 2008 .

[The troponin assay in a cardiac emergency unit: especially to exclude severe cardiac risk].

F. Zijlstra, K. Miedema, M. Nienhuis, 2003, Nederlands tijdschrift voor geneeskunde.

An unusual cause of T-wave inversion

J. Ottervanger, W. Beukema, M. Nienhuis, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents 2-Year Follow-Up of the Randomized TWENTE Trial

M. Stoel, G. Linssen, C. Birgelen, 2013 .

Prognostic implications of myocardial injury around percutaneous coronary interventions

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2008 .

Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents.

M. Stoel, C. von Birgelen, G. Linssen, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.